These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20044478)

  • 1. Analysis of binding sites on complement factor I that are required for its activity.
    Nilsson SC; Nita I; Månsson L; Groeneveld TW; Trouw LA; Villoutreix BO; Blom AM
    J Biol Chem; 2010 Feb; 285(9):6235-45. PubMed ID: 20044478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of binding sites on complement factor I using artificial N-linked glycosylation.
    Sanchez-Gallego JI; Groeneveld TW; Krentz S; Nilsson SC; Villoutreix BO; Blom AM
    J Biol Chem; 2012 Apr; 287(17):13572-83. PubMed ID: 22393059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement factor I in health and disease.
    Nilsson SC; Sim RB; Lea SM; Fremeaux-Bacchi V; Blom AM
    Mol Immunol; 2011 Aug; 48(14):1611-20. PubMed ID: 21529951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I.
    Nilsson SC; Kalchishkova N; Trouw LA; Fremeaux-Bacchi V; Villoutreix BO; Blom AM
    Eur J Immunol; 2010 Jan; 40(1):172-85. PubMed ID: 19877009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for complement factor I control and its disease-associated sequence polymorphisms.
    Roversi P; Johnson S; Caesar JJ; McLean F; Leath KJ; Tsiftsoglou SA; Morgan BP; Harris CL; Sim RB; Lea SM
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12839-44. PubMed ID: 21768352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
    Blom AM; Villoutreix BO; Dahlbäck B
    J Biol Chem; 2003 Oct; 278(44):43437-42. PubMed ID: 12893820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic, molecular and functional analyses of complement factor I deficiency.
    Nilsson SC; Trouw LA; Renault N; Miteva MA; Genel F; Zelazko M; Marquart H; Muller K; Sjöholm AG; Truedsson L; Villoutreix BO; Blom AM
    Eur J Immunol; 2009 Jan; 39(1):310-23. PubMed ID: 19065647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling.
    Chamberlain D; Ullman CG; Perkins SJ
    Biochemistry; 1998 Oct; 37(40):13918-29. PubMed ID: 9760226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.
    Malm S; Jusko M; Eick S; Potempa J; Riesbeck K; Blom AM
    PLoS One; 2012; 7(4):e34852. PubMed ID: 22514678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
    Kavanagh D; Richards A; Noris M; Hauhart R; Liszewski MK; Karpman D; Goodship JA; Fremeaux-Bacchi V; Remuzzi G; Goodship TH; Atkinson JP
    Mol Immunol; 2008 Jan; 45(1):95-105. PubMed ID: 17597211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.
    Okroj M; Hsu YF; Ajona D; Pio R; Blom AM
    Mol Immunol; 2008 Jan; 45(1):169-79. PubMed ID: 17548110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of zinc on factor I cofactor activity of C4b-binding protein and factor H.
    Blom AM; Kask L; Ramesh B; Hillarp A
    Arch Biochem Biophys; 2003 Oct; 418(2):108-18. PubMed ID: 14522582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly.
    Escudero-Esparza A; Kalchishkova N; Kurbasic E; Jiang WG; Blom AM
    FASEB J; 2013 Dec; 27(12):5083-93. PubMed ID: 23964079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency.
    Nita IM; Genel F; Nilsson SC; Smart J; Truedsson L; Choo S; Blom AM
    Mol Immunol; 2011 Apr; 48(8):1068-72. PubMed ID: 21316765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K; Seya T; Yanagi Y; Pesando JM; Johnson PM; Okabe M; Ueda S; Ariga H; Nagasawa S
    J Biol Chem; 1995 Jun; 270(25):15148-52. PubMed ID: 7541036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
    Subramanian VB; Clemenza L; Krych M; Atkinson JP
    J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional evaluation of complement factor I variants by immunoassays and SDS-PAGE.
    Gerogianni A; Baas LM; Sjöström DJ; van de Kar NCAJ; Pullen M; van de Peppel SJ; Nilsson PH; van den Heuvel LP
    Front Immunol; 2023; 14():1279612. PubMed ID: 37954579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.